Relationship between peripheral arterial reactive hyperemia and residual platelet reactivity after 600 mg clopidogrel

Journal of Thrombosis and Thrombolysis

Volumn 32, Issue 1, 2011, Pages 64-71

  Hamilos, Michalis ^a   Muller, Olivier ^a   Ntalianis, Argyrios ^a   Trana, Catalina ^a   Bartunek, Jozef ^a   Sarno, Giovanna ^a   Mangiacapra, Fabio ^a   Dierickx, Karen ^a   Meeus, Peter ^a   Cuisset, Thomas ^a   Bruyne, Bernard De ^a   Wijns, William ^a   Barbato, Emanuele ^a  

^a OLV HOSPITAL   (Belgium)

Author keywords

Clopidogrel; Endothelium; Percutaneous coronary intervention; Platelet r.eactivity.

Indexed keywords

ACETYLSALICYLIC ACID; CLOPIDOGREL; PURINERGIC P2Y12 RECEPTOR;

ADULT; AGED; ARTICLE; CLINICAL ARTICLE; CONTROLLED STUDY; CORONARY ARTERY DISEASE; CORRELATIONAL STUDY; DOSE RESPONSE; FEMALE; HUMAN; HYPEREMIA; LOADING DRUG DOSE; MALE; PERCUTANEOUS CORONARY INTERVENTION; POINT OF CARE TESTING; PRIORITY JOURNAL; PROTEIN DETERMINATION; PROTEIN EXPRESSION; SCORING SYSTEM; THROMBOCYTE AGGREGATION INHIBITION; THROMBOCYTE FUNCTION; TONOMETRY; VASCULAR ENDOTHELIUM;

ACUTE CORONARY SYNDROME; AGED; CORONARY ARTERY DISEASE; ENDOTHELIUM, VASCULAR; FEMALE; HUMANS; HYPEREMIA; MALE; MIDDLE AGED; PLATELET ACTIVATION; PLATELET AGGREGATION INHIBITORS; PLATELET FUNCTION TESTS; TICLOPIDINE; TIME FACTORS;

EID: 80052464307     PISSN: 09295305     EISSN: 1573742X     Source Type: Journal    
DOI: 10.1007/s11239-011-0557-x     Document Type: Article

References (36)

1. Yusuf S, Zhao F, Mehta SR, Chrolavicius S, Tognoni G, Fox KK (2001) Clopidogrel in Unstable Angina to Prevent Recurrent Events Trial Investigators. Effects of clopidogrel in addition to aspirin in patients with acute coronary syndromes without ST-segment elevation. N Engl J Med 345(7):494-502 (Pubitemid 32758501)
2. Mehta SR, Yusuf S, Peters RJ et al (2001) Clopidogrel in Unstable angina to prevent Recurrent Events trial (CURE) Investigators. Effects of pretreatment with clopidogrel and aspirin followed by long-term therapy in patients undergoing percutaneous coronary intervention: the PCI-CURE study. Lancet 358:527-533 (Pubitemid 32772726)
3. Steinhubl SR, Berger PB, Mann JT III et al, CREDO Investigators (2002) Clopidogrel for the reduction of events during observation. Early and sustained dual oral antiplatelet therapy following percutaneous coronary intervention: a randomized controlled trial. JAMA 19:2411-2420 (Pubitemid 35340537)
4. Ziemianin B, Olszanecki R, Uracz W, Marcinkiewicz E, Gryglewski RJ (1999) Thienopyridines: effects on cultured endothelial cells. J Physiol Pharmacol 50:597-604 (Pubitemid 30022138)
5. Jakubowski A, Chlopicki S, Olszanecki R et al (2005) Endothelial action of thienopyridines and thienopyrimidinones in the isolated guinea pig heart. Prostaglandins Leukot Essent Fatty Acids 72:139-145 (Pubitemid 40051231)
6. Heitzer T, Rudolph V, Schwedhelm E et al (2006) Clopidogrel improves systemic endothelial nitric oxide bioavailability in patients with coronary artery disease: evidence for antioxidant and antiinflammatory effects. Arterioscler Thromb Vasc Biol 26(7):1648-1652 (Pubitemid 44288996)
7. Warnholtz A, Ostad MA, Velich N et al (2008) A single loading dose of clopidogrel causes dose-dependent improvement of endothelial dysfunction in patients with stable coronary artery disease: results of a double-blind, randomized study. Atherosclerosis 196:689-695
8. Hamburg NM, Keyes MJ, Larson MG et al (2008) Crosssectional relations of digital vascular function to cardiovascular risk factors in the Framingham Heart Study. Circulation 117(19): 2467-2474 (Pubitemid 351670453)
9. Bonetti PO, Pumper GM, Higano ST, Holmes DR, Kuvin JT, Lerman A (2004) Noninvasive identification of patients with early coronary atherosclerosis by assessment of digital reactive hyperemia. J Am Coll Cardiol 44:2137-2141 (Pubitemid 39576032)
10. Werner N, Wassmann S, Ahlers P, Kosiol S, Nickenig G (2006) Circulating CD31?/annexin V? apoptotic microparticles correlate with coronary endothelial function in patients with coronary artery disease. Arterioscler Thromb Vasc Biol 26(1): 112-116 (Pubitemid 43732236)
11. Boulanger CM, Amabile N, Tedgui A (2006) Circulating microparticles: a potential prognostic marker for atherosclerotic vascular disease. Hypertension 48(2):180-186 (Pubitemid 44309805)
12. Bernal-Mizrachi L, Jy W, Fierro C et al (2004) Endothelial microparticles correlate with high-risk angiographic lesions in acute coronary syndromes. Int J Cardiol 97(3):439-446 (Pubitemid 39550693)
13. Patti G, Nusca A, Mangiacapra F, Gatto L, D'Ambrosio A, Di Sciascio G (2008) Point-of-care measurement of clopidogrel responsiveness predicts clinical outcome in patients undergoing percutaneous coronary intervention results of the ARMYDAPRO (Antiplatelet therapy for Reduction of MYocardial Damage during Angioplasty-Platelet Reactivity Predicts Outcome) study. J Am Coll Cardiol 52(14):1128-1133
14. Price MJ, Endemann S, Gollapudi RR et al (2008) Prognostic significance of post-clopidogrel platelet reactivity assessed by a point-of-care assay on thrombotic events after drug-eluting stent implantation. Eur Heart J 29(8):992-1000 (Pubitemid 351844676)
15. Crandall JP, Shamoon H, Cohen HW et al (2009) Post-challenge hyperglycemia in older adults is associated with increased cardiovascular risk profile. J Clin Endocrinol Metab 94(5):1595-1600
16. Gawaz M, Neumann FJ, Ott I et al (1997) Vitronectin receptor (alpha(v)beta3) mediates platelet adhesion to the luminal aspect of endothelial cells: implications for reperfusion in acute myocardial infarction. Circulation 96:1809-1818 (Pubitemid 27400738)
17. May AE, Seizer P, Gawaz M (2008) Platelets: inflammatory firebugs of vascular walls. Arterioscler Thromb Vasc Biol 28(3): s5-s10
18. Gawaz M, Langer H, May AE (2005) Platelets in inflammation and atherogenesis. J Clin Investig 115(12):3378-3384 (Pubitemid 43121822)
19. Furman MI, Benoit SE, Barnard MR et al (1998) Increased platelet reactivity and circulating monocyte-platelet aggregates in patients with stable coronary artery disease. J Am Coll Cardiol 31(2):352-358 (Pubitemid 28153455)
20. Davi G, Patrono C (2007) Platelet activation and atherothrombosis. N Engl J Med 357:2482-2494
21. Husain S, Andrews NP, Mulcahy D, Panza JA, Quyyumi AA (1998) Aspirin improves endothelial dysfunction in atherosclerosis. Circulation 97:716-720 (Pubitemid 28135332)
22. Quyyumi AA (1998) Effects of aspirin on endothelial dysfunction in atherosclerosis. Am J Cardiol 82(10A):31S-33S
23. Heitzer T, Ollmann I, Koke K, Meinertz T, Munzel T (2003) Platelet glycoprotein IIb/IIIa receptor blockade improves vascular nitric oxide bioavailability in patients with coronary artery disease. Circulation 108:536-541 (Pubitemid 36961166)
24. Morel O, Toti F, Hugel B et al (2006) Procoagulant microparticles: disrupting the vascular homeostasis equation? Arterioscler Thromb Vasc Biol 26:2594-2604
25. Bernal-Mizrachi L, Jy W, Jimenez JJ et al (2003) High levels of circulating endothelial microparticles in patients with acute coronary syndromes. Am Heart J 145:962-970 (Pubitemid 36688245)
26. Ettelaie C, Collier ME, James NJ, Li C (2006) Induction of tissue factor expression and release as microparticles in ECV304 cell line by Chlamydia pneumoniae infection. Atherosclerosis 190:343-351 (Pubitemid 46074050)
27. Leroyer AS, Isobe H, Lesèche G (2007) Cellular origins and thrombogenic activity of microparticles isolated from human atherosclerotic plaques. J Am Coll Cardiol 49:772-777 (Pubitemid 46240708)
28. Mause SF, von Hundelshausen P, Zernecke A, Koenen RR, Weber C (2005) Platelet microparticles: a transcellular delivery system for RANTES promoting monocyte recruitment on endothelium. Arterioscler Thromb Vasc Biol 25:1512-1518 (Pubitemid 40923377)
29. Morel O, Pereira B, Averous G et al (2009) Increased levels of procoagulant tissue factor-bearing microparticles within the occluded coronary artery of patients with ST-segment elevation myocardial infarction: role of endothelial damage and leukocyte activation. Atherosclerosis 204:636-641
30. Juul-Möller S, Edvardsson N, Jahnmatz B, Rosén A, Sorensen S, Ömblus R (1992) Double-blind trial of aspirin in primary prevention of myocardial infarction in patients with stable chronic angina pectoris. The Swedish Angina Pectoris Aspirin (SAPAT) trial. Lancet 340:1421-1425
31. Muller O, Hamilos M, Bartunek J, Ulrichts H, Mangiacapra F, Holz JB, Ntalianis A, Trana C, Dierickx K, Vercruysse K, De Bruyne B, Wijns W, Barbato E (2010) Relation of endothelial function to residual platelet reactivity after clopidogrel in patients with stable angina pectoris undergoing percutaneous coronary intervention. Am J Cardiol 105:333-338
32. Ostad MA, Nick E, Paixao-Gatinho V, Schnorbus B, Schiewe R, Tschentscher P, Munzel T, Warnholtz A (2011) Lack of evidence for pleiotropic effects of clopidogrel on endothelial function and inflammation in patients with stable coronary artery disease: results of the double-blind, randomized CASSANDRA study. Clin Res Cardiol 100(1):29-36
33. Wiviott SD, Braunwald E, McCabe CH, Montalescot G, Ruzyllo W, Gottlieb S, Neumann FJ, Ardissino D, De Servi S, Murphy SA, Riesmeyer J, Weerakkody G, Gibson CM, Antman EM, Triton-TIMI 38 Investigators (2007) Prasugrel versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 357(20):2001-2015 (Pubitemid 350106708)
34. Wallentin L, Becker RC, Budaj A, Cannon CP, Emanuelsson H, Held C, Horrow J, Husted S, James S, Katus H, Mahaffey KW, Scirica BM, Skene A, Steg PG, Storey RF, Harrington RA, Freij A, Thorsen M, PLATO Investigators (2009) Ticagrelor versus clopidogrel in patients with acute coronary syndromes. N Engl J Med 361(11):1045-1057
35. Collet JP, Hulot JS, Pena A et al (2009) Cytochrome P450 2C19 polymorphism in young patients treated with clopidogrel after myocardial infarction: a cohort study. Lancet 373:309-317
36. Azevedo ER, Schofield AM, Kelly S, Parker JD (2001) Nitroglycerin withdrawal increases endothelium-dependent vasomotor response to acetylcholine. J Am Coll Cardiol 37:505-509